Market Overview:
The global malaria treatment market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The market growth can be attributed to factors such as the increasing incidence of malaria, rising demand for effective and affordable malaria treatments, and growing awareness about malaria prevention measures. Based on type, the global malaria treatment market is segmented into quinine, chloroquine, proguanil, mefloquine, pyrimethamine and other drugs. Quinine is currently the most commonly used drug for treating uncomplicated falciparum malaria in adults and children. Chloroquine is also a widely used drug for treating uncomplicated falciparum malaria in adults and children. Mefloquine has been increasingly recommended by WHO as first-line therapy against P . vivax infections resistant to chloroquinesince 2010; it was also added in 2013 as a preferred option for chemoprophylaxis against P .
Product Definition:
The treatment of malaria includes medications to kill the parasites that cause the infection and to prevent further illness.
Quinine:
Quinine is a quinine molecule bound to an antibiotic. It was first isolated from the bark of the Cinchona tree, which is found only in South America and Africa. The drug has been used for centuries as an effective treatment for malaria, and it continues to be one of the most common medications used around the world today.
Chloroquine:
Chloroquine is an antimetabolite. It is a medication used for the treatment of malaria and other diseases caused by parasites in the body. The drug was first developed as an anti-viral agent during World War II, but it has been found to be effective against a number of viruses and bacteria since then. Chloroquine can treat both acute and chronic infections, including malaria, which makes it one of the most widely prescribed medications globally.
Application Insights:
The global malaria treatment market by application is segmented into hospital pharmacy, retail pharmacy, and e-commerce. Hospital pharmacies accounted for the largest share in the market as a result of high product availability and easy accessibility to patients admitted in hospitals for diagnosis or treatment of malaria.
Retail pharmacies are expected to witness lucrative growth over the forecast period due to increasing awareness among consumers regarding effective medication practices. Moreover, growing demand for self-treatment kits at affordable prices will drive this segment over the forecast period. Quinine sulfate is one of the most commonly sold products through retail channels owing to its low cost and high efficacy against falciparum malaria infection when used within appropriate guidelines. However, chloroquine phosphate remains as a more preferred option among consumers globally due largely to its lower price coupled with better efficacy against both falciparum & vivax malarias compared to quinine sulfate (Ref).
Regional Analysis:
Asia Pacific dominated the global market in 2017. The region is expected to maintain its position during the forecast period due to increasing cases of malaria and growing demand for antimalarial drugs. Moreover, initiatives by governments of various countries such as India, China and Singapore are expected to boost growth over the coming years. For instance, in 2015-2016 academic year, Indian Council of Medical Research (ICMR) launched a national immunization program against five major diseases namely dengue fever, Japanese encephalitis virus (JE), rotavirus diarrheal disease, poliomyelitis and malaria. This initiative covered over 12 million children from 1 year old till 5 years old under two phases i.e.
Growth Factors:
- Increasing incidence of malaria: The incidence of malaria is increasing at a rapid pace across the globe. This is primarily owing to the increase in international travel and trade, climatic changes, and unhygienic living conditions. This is expected to drive the demand for malaria treatment products in the coming years.
- Growing awareness about malaria: There is a growing awareness among people about malaria and its symptoms. This has led to an increase in the number of people seeking medical help for early diagnosis and treatment of this disease. This is likely to boost the demand for malaria treatment products in the near future.
- Rising R&D expenditure by key players: Key players operating in this market are investing heavily in R&D activities with a view to develop new and innovative products that can cater to unmet needs of patients suffering from Malaria infection .This will help them gain a stronghold over this market In forthcoming years .This will also propel growth prospects for Malaria Treatment market during forecast period .
Scope Of The Report
Report Attributes
Report Details
Report Title
Malaria Treatment Market Research Report
By Type
Quinine, Chloroquine, Proguanil, Mefloquine, Pyrimethamine, Other
By Application
Hospital Pharmacy, Retail Pharmacy, E-Commerce
By Companies
Advanz Pharmaceutical, Ipca Laboratories Ltd, Zydus Cadila, Glenmark, Olympus Corporation, Abbott, Sanofi, GlaxoSmithKline plc., Novartis AG, TEVA PHARMACEUTICAL INDUSTRIES LTD
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
195
Number of Tables & Figures
137
Customization Available
Yes, the report can be customized as per your need.
Global Malaria Treatment Market Report Segments:
The global Malaria Treatment market is segmented on the basis of:
Types
Quinine, Chloroquine, Proguanil, Mefloquine, Pyrimethamine, Other
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital Pharmacy, Retail Pharmacy, E-Commerce
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Advanz Pharmaceutical
- Ipca Laboratories Ltd
- Zydus Cadila
- Glenmark
- Olympus Corporation
- Abbott
- Sanofi
- GlaxoSmithKline plc.
- Novartis AG
- TEVA PHARMACEUTICAL INDUSTRIES LTD
Highlights of The Malaria Treatment Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Quinine
- Chloroquine
- Proguanil
- Mefloquine
- Pyrimethamine
- Other
- By Application:
- Hospital Pharmacy
- Retail Pharmacy
- E-Commerce
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Malaria Treatment Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Malaria treatment is a combination of medications to kill the malaria parasite and prevent its spread. Treatment may include: n-A prophylactic dose of an anti-malarial drug before traveling to an area where malaria is common n-Treatment with one or more anti-malarial drugs when you get sick with malaria n-Chemotherapy, which uses drugs to kill cancer cells
Some of the key players operating in the malaria treatment market are Advanz Pharmaceutical, Ipca Laboratories Ltd, Zydus Cadila, Glenmark, Olympus Corporation, Abbott, Sanofi, GlaxoSmithKline plc., Novartis AG, TEVA PHARMACEUTICAL INDUSTRIES LTD.
The malaria treatment market is expected to grow at a compound annual growth rate of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Malaria Treatment Market Overview 4.1 Introduction 4.1.1 Market Taxonomy 4.1.2 Market Definition 4.1.3 Macro-Economic Factors Impacting the Market Growth 4.2 Malaria Treatment Market Dynamics 4.2.1 Market Drivers 4.2.2 Market Restraints 4.2.3 Market Opportunity 4.3 Malaria Treatment Market - Supply Chain Analysis 4.3.1 List of Key Suppliers 4.3.2 List of Key Distributors 4.3.3 List of Key Consumers 4.4 Key Forces Shaping the Malaria Treatment Market 4.4.1 Bargaining Power of Suppliers 4.4.2 Bargaining Power of Buyers 4.4.3 Threat of Substitution 4.4.4 Threat of New Entrants 4.4.5 Competitive Rivalry 4.5 Global Malaria Treatment Market Size & Forecast, 2018-2028 4.5.1 Malaria Treatment Market Size and Y-o-Y Growth 4.5.2 Malaria Treatment Market Absolute $ Opportunity
Chapter 5 Global Malaria Treatment Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Malaria Treatment Market Size Forecast by Type
5.2.1 Quinine
5.2.2 Chloroquine
5.2.3 Proguanil
5.2.4 Mefloquine
5.2.5 Pyrimethamine
5.2.6 Other
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Malaria Treatment Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Malaria Treatment Market Size Forecast by Applications
6.2.1 Hospital Pharmacy
6.2.2 Retail Pharmacy
6.2.3 E-Commerce
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Malaria Treatment Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Malaria Treatment Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Malaria Treatment Analysis and Forecast
9.1 Introduction
9.2 North America Malaria Treatment Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Malaria Treatment Market Size Forecast by Type
9.6.1 Quinine
9.6.2 Chloroquine
9.6.3 Proguanil
9.6.4 Mefloquine
9.6.5 Pyrimethamine
9.6.6 Other
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Malaria Treatment Market Size Forecast by Applications
9.10.1 Hospital Pharmacy
9.10.2 Retail Pharmacy
9.10.3 E-Commerce
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Malaria Treatment Analysis and Forecast
10.1 Introduction
10.2 Europe Malaria Treatment Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Malaria Treatment Market Size Forecast by Type
10.6.1 Quinine
10.6.2 Chloroquine
10.6.3 Proguanil
10.6.4 Mefloquine
10.6.5 Pyrimethamine
10.6.6 Other
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Malaria Treatment Market Size Forecast by Applications
10.10.1 Hospital Pharmacy
10.10.2 Retail Pharmacy
10.10.3 E-Commerce
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Malaria Treatment Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Malaria Treatment Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Malaria Treatment Market Size Forecast by Type
11.6.1 Quinine
11.6.2 Chloroquine
11.6.3 Proguanil
11.6.4 Mefloquine
11.6.5 Pyrimethamine
11.6.6 Other
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Malaria Treatment Market Size Forecast by Applications
11.10.1 Hospital Pharmacy
11.10.2 Retail Pharmacy
11.10.3 E-Commerce
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Malaria Treatment Analysis and Forecast
12.1 Introduction
12.2 Latin America Malaria Treatment Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Malaria Treatment Market Size Forecast by Type
12.6.1 Quinine
12.6.2 Chloroquine
12.6.3 Proguanil
12.6.4 Mefloquine
12.6.5 Pyrimethamine
12.6.6 Other
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Malaria Treatment Market Size Forecast by Applications
12.10.1 Hospital Pharmacy
12.10.2 Retail Pharmacy
12.10.3 E-Commerce
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Malaria Treatment Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Malaria Treatment Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Malaria Treatment Market Size Forecast by Type
13.6.1 Quinine
13.6.2 Chloroquine
13.6.3 Proguanil
13.6.4 Mefloquine
13.6.5 Pyrimethamine
13.6.6 Other
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Malaria Treatment Market Size Forecast by Applications
13.10.1 Hospital Pharmacy
13.10.2 Retail Pharmacy
13.10.3 E-Commerce
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Malaria Treatment Market: Competitive Dashboard
14.2 Global Malaria Treatment Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Advanz Pharmaceutical
14.3.2 Ipca Laboratories Ltd
14.3.3 Zydus Cadila
14.3.4 Glenmark
14.3.5 Olympus Corporation
14.3.6 Abbott
14.3.7 Sanofi
14.3.8 GlaxoSmithKline plc.
14.3.9 Novartis AG
14.3.10 TEVA PHARMACEUTICAL INDUSTRIES LTD